Clinical, epidemiological and molecular data reported in the last 5 years h
ave provided strong evidence that genetic factors are important in suscepti
bility to both Crohn's disease and ulcerative colitis. The model of disease
inheritance which best fits the epidemiological data is that Crohn's disea
se and ulcerative colitis are related polygenic diseases. However, genetic
heterogeneity is likely to be extensive, and may well underlie the variabil
ity in clinical presentation associated with inflammatory bowel disease. Co
nsiderable progress has already been made in identifying potential disease
susceptibility loci using the technique of genome-wide scanning. There is o
ptimism that international collaborative studies will allow fine mapping of
the loci implicated on chromosomes 16 and 12. The identification of novel
susceptibility genes has become a realistic goal for investigators. Once th
is has been achieved, there are likely to be immediate clinical benefits, b
oth in understanding disease gathophysiology, and in disease management.